Inari Medical Inc (NARI)
38.24
+0.06
(+0.16%)
USD |
NASDAQ |
Apr 25, 13:36
Inari Medical SG&A Expense (Quarterly): 101.49M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 101.49M |
September 30, 2023 | 88.28M |
June 30, 2023 | 85.59M |
March 31, 2023 | 85.70M |
December 31, 2022 | 80.12M |
September 30, 2022 | 75.83M |
June 30, 2022 | 73.16M |
March 31, 2022 | 63.73M |
December 31, 2021 | 54.47M |
September 30, 2021 | 56.10M |
Date | Value |
---|---|
June 30, 2021 | 42.90M |
March 31, 2021 | 36.90M |
December 31, 2020 | 31.39M |
September 30, 2020 | 23.08M |
June 30, 2020 | 18.88M |
March 31, 2020 | 16.39M |
December 31, 2019 | 13.87M |
September 30, 2019 | 10.10M |
June 30, 2019 | 7.803M |
March 31, 2019 | 5.426M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
7.803M
Minimum
Jun 2019
101.49M
Maximum
Dec 2023
50.83M
Average
54.47M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
Conmed Corp | 117.96M |
SI-BONE Inc | 37.02M |
Stereotaxis Inc | 5.83M |
Electromed Inc | 8.175M |
Myomo Inc | 4.66M |